New incident report
Incident Report Number: 2019-3618
Registrant Reference Number: USA-BAYERBAH-2019-US0034895 (Report 577122)
Registrant Name (Full Legal Name no abbreviations): Bayer inc
Address: 2920 Matheson Blvd
City: Mississaugua
Prov / State: ON
Country: Canada
Postal Code: L4W 5R6
Domestic Animal
Country: UNITED STATES
Prov / State: GEORGIA
PMRA Registration No. PMRA Submission No. EPA Registration No. 11556-155
Product Name: Seresto collar large dog
Other (specify)
COLLARYes
Other Units: COLLAR
Site: Animal / Usage sur un animal domestique
Animal's Owner
Dog / Chien
Beagle
1
Male
3
27.216
kg
Skin
>24 hrs <=3 days / >24 h <=3 jours
>24 hrs <=3 days / >24 h <=3 jours
System
Unknown / Inconnu
Unknown
Unknown
Died
Treatment / Traitement
(eg. description of the frequency and severity of the symptoms
On 25-Jun-2019, the canine became paralyzed and was laying on the ground, and started having seizures, vomiting, breathing hard and became unresponsive. The canine was examined by a veterinarian and the canine had elevated liver and kidney enzymes. On 26-Jun-2019, the canine died; no necropsy was performed.
Death
O - Unclassifiable/unassessable - Reported signs paralysis, unresponsive to stimuli are not expected following appropriate topical product application as inconsistent with product's pharmacological profile. The product is not anticipated to cause serious neurological disorders such as seizure after appropriate topical product administration as the controlled release mechanism assures release of only low doses of active ingredient at a time. But seizures were reported in connection with product use in dogs. However, it is known that overdose of 5 collars around the neck of adult dogs for an 8 months period and in 7 week old puppies for a 6 months period did not cause serious signs. This is supported by the extremely low systemic exposure with imidacloprid and flumethrin, particularly during the first week after application and also thereafter. Even with oral product exposure, seizures are not seen. Merely gastrointestinal signs may occur. Any action or treatment may trigger seizures in an animal with a respective disposition. Various etiologies exist for seizure events or paroxysmal signs, e.g. heart disorder, development disorder, metabolic disorder, infection, intoxication, idiopathic epilepsy, trauma, neoplasms. Vomiting and abnormal breathing likely associated with reported seizures. Later reported elevated liver enzymes and renal parameters and death are also not expected following appropriate topical product application as inconsistent with product's pharmacological profile. Oral exposure to the collar is not expected to cause serious signs either. No signs of anaphylaxis reported which would have occurred in close proximity to the collar application. Time to onset is short though. Other unrelated causes must be considered in this case. Considering low level of information (animal health status, medical history and necropsy report are unknown), a product relation is unassessable.